Comparison results
Results: Differences Similar | ✘C74 | ✘C96.2 | ||||||||||
Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
Distinctive symptoms | ||||||||||||
Register, to see more distinctive signs of diseases and studies | 100% | — | ||||||||||
Register, to see more distinctive signs of diseases and studies | — | 47% | ||||||||||
pheochromocytoma | 84% | — | ||||||||||
feeling of fullness | — | 26% | ||||||||||
high risk of prostate cancer | 61% | — | ||||||||||
chronic myeloid leukemia | — | 22% | ||||||||||
metastases | 51% | — | ||||||||||
myelofibrosis | — | 22% | ||||||||||
insulinoma | 49% | — | ||||||||||
chronic leukemia | — | 21% | ||||||||||
lee-fraumeni syndrome | 48% | — | ||||||||||
myeloid metaplasia | — | 20% | ||||||||||
tumors of the parathyroid glands | 47% | — | ||||||||||
chronic lymphocytic | — | 18% | ||||||||||
neuroblastoma | 47% | — | ||||||||||
hemorrhagic syndrome | — | 17% | ||||||||||
brain tumors in children | 46% | — | ||||||||||
multiple organ failure | — | 16% | ||||||||||
facial hair growth | 46% | — | ||||||||||
aggressive | — | 13% | ||||||||||
breast sarcoma | 43% | — | ||||||||||
control issues | — | 12% | ||||||||||
itsenko-cushing syndrome (hypercorticism) | 41% | — | ||||||||||
patient's condition | — | 11% | ||||||||||
discomfort in the chest | 40% | — | ||||||||||
hyperaldosteronism | 40% | — | ||||||||||
prostate cancer | 40% | — | ||||||||||
vascular tumor | 40% | — | ||||||||||
muscle weakness | 39% | — | ||||||||||
pancreatic cancer | 39% | — | ||||||||||
pituitary tumors | 39% | — | ||||||||||
weakness of the muscles of the hands | 38% | — | ||||||||||
impaired prostate function | 38% | — | ||||||||||
posttransfusion complications | 37% | — | ||||||||||
fat deposits | 36% | — | ||||||||||
brain cancer | 36% | — | ||||||||||
benign epithelial tumors | 36% | — | ||||||||||
weakness in the hands | 35% | — | ||||||||||
weakness | 35% | — | ||||||||||
thin skin | 35% | — | ||||||||||
breast cancer | 35% | — | ||||||||||
ones weakness in the leg muscles | 35% | — | ||||||||||
solid tumors | 34% | — | ||||||||||
cns tumors | 34% | — | ||||||||||
effects of radiation therapy | 34% | — | ||||||||||
weakness in the legs | 33% | — | ||||||||||
bone tumors | 33% | — | ||||||||||
serum sickness | 33% | — | ||||||||||
breast cancer | 33% | — | ||||||||||
breast tumor | 33% | — | ||||||||||
oncology relatives | 33% | — | ||||||||||
effects of taking hormones | 32% | — | ||||||||||
brain tumor | 32% | — | ||||||||||
illness from stress | 31% | — | ||||||||||
fainting | 31% | — | ||||||||||
brain tumor | 30% | — | ||||||||||
cancer | 55% | 24% | ||||||||||
disorders of consciousness | 29% | — | ||||||||||
adaptation disorders | 29% | — | ||||||||||
radiation therapy | 29% | — | ||||||||||
oncology | 52% | 22% | ||||||||||
radiation damage | 28% | — | ||||||||||
tachycardia | 28% | — | ||||||||||
scarring | 28% | — | ||||||||||
benign neoplasms | 28% | — | ||||||||||
hormonal disorders | 27% | — | ||||||||||
diabetes mellitus | 27% | — | ||||||||||
palpitations | 27% | — | ||||||||||
headaches | 27% | — | ||||||||||
recovery period | 26% | — | ||||||||||
consequences of operation | 25% | — | ||||||||||
there are no complaints | 25% | — | ||||||||||
blood diseases | 34% | 16% | ||||||||||
consequences of taking medications | 24% | 11% | ||||||||||
leukemia | 34% | 27% | ||||||||||
lymphocytic | 34% | 27% |
Instructions
Video
|